共 120 条
[1]
Anderson JL(2013)2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction J Am Coll Cardiol 61 e179-e347
[2]
Adams CD(2013)2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines J Am Coll Cardiol 61 e78-140
[3]
Antman EM(2015)Novel antiplatelet agents in acute coronary syndrome Nat Rev Cardiol 12 30-47
[4]
O’Gara PT(2014)Resistance to antiplatelet drugs: what progress has been made? Expert Opin Pharmacother 15 2553-2564
[5]
Kushner FG(2015)Pharmacology of antithrombotic drugs: an assessment of oral antiplatelet and anticoagulant treatments Lancet 386 281-291
[6]
Ascheim DD(2012)Meta-analyses of the association between cytochrome Heart 98 100-108
[7]
Franchi F(2011) loss- and gain-of-function polymorphisms and cardiovascular outcomes in patients with coronary artery disease treated with clopidogrel Clin Pharmacol Ther 90 328-332
[8]
Angiolillo DJ(2010)Clinical pharmacogenetics implementation consortium guidelines for cytochrome P450-2C19 ( JAMA 304 1821-1830
[9]
Tantry US(2007)) genotype and clopidogrel therapy N Engl J Med 357 2001-2015
[10]
Gesheff M(2009)Reduced-function N Engl J Med 361 1045-1057